YOLFTbeta
Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp. Ordinary Shares

DMII · NASDAQ · Financial Services / Shell Companies

10.24USD-0.00 (-0.05%)

Price History

Full chart

Market Stats

Previous Close10.25
Open10.24
Day Range10.24 – 10.24
52-Week Range9.86 – 10.33
Volume150.05K
Market Cap646.55M
P/E (TTM)35.00
Forward P/E0.00
EPS0.29
Dividend Yield0.00%
50-Day Avg10.13
200-Day Avg10.03

About

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Company Details

  • SectorFinancial Services
  • IndustryShell Companies
  • CEOMr. Roger Bendelac
  • Headquarters420 Lexington Avenue, New York, NY, United States, 10170, USA

Leadership

  • Mr. Roger BendelacChief Executive Officer · b. 1957

Financials

Income Statement

Currency: USD2024-12-312025-12-31
Total Revenue-0
Operating Income-151.72K-1.30M
EBITDA-151.72K-1.30M
Net Income-151.72K4.19M

Balance Sheet

Currency: USD2024-12-312025-12-31
Total Assets138.06K504.96M
Total Liabilities254.78K17.80M
Total Equity-116.72K487.16M
Cash17.04K223
Total Debt250.10K-
Net Debt233.06K-223

Cash Flow

Currency: USD2024-12-312025-12-31
Operating Cash Flow-194.30K-1.02M
Investing Cash Flow--500.00M
Financing Cash Flow211.33K501.00M
Capital Expenditure00
Free Cash Flow-194.30K-1.02M
FCF to OCF100.00%100.00%

Earnings

Report DateNov 18, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.00---
EPS Actual0.000.070.070.07
Surprise----
Timing----

Key Statistics & Ratios

Market Cap646.55M
Enterprise Value647.47M
Trailing P/E35.00
Forward P/E0.00
Price / Sales0.00
Price / Book1.30
EPS0.29
Book Value-0.281
Revenue (TTM)0
Gross Profit (TTM)-812.11K
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-0.32%
Shares Outstanding63.70M
Shares Float54.01M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
72.88%
Insiders
15.21%
Retail / Other
11.91%

Top Institutional Holders

  • Mmcap International Inc. Spc
    2.70M4.24%
  • Magnetar Financial LLC
    2.70M4.24%
  • Karpus Management Inc
    2.60M4.08%
  • Glazer Capital, LLC
    2.34M3.68%
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
    2.00M3.14%
  • Millennium Management LLC
    1.99M3.13%
  • Hudson Bay Capital Management LP
    1.97M3.09%
  • Wolverine Asset Management LLC
    1.80M2.82%
  • Tenor Capital Management Co Lp
    1.50M2.35%
  • Polar Asset Management Partners
    1.50M2.35%
  • D. E. Shaw & Co LP
    1.48M2.32%
  • HGC Investment Management Inc.
    1.23M1.93%
  • Cnh Partners, LLC
    1.11M1.75%
  • Aristeia Capital, LLC
    1.10M1.73%
  • First Trust Capital Management L.P.
    1.07M1.68%
  • Omers Administration Corp
    1.00M1.57%
  • Davidson Kempner Capital Management LP
    1.00M1.57%
  • Two Sigma Investments LLC
    886.54K1.39%

Top Fund Holders

  • CrossingBridge Low Dur Hi Inc Instl
    1.07M1.69%
  • First Trust Merger Arbitrage Cl I
    913.21K1.43%